Patents by Inventor Christopher Redman

Christopher Redman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOMARKERS AND USES THEREOF
    Publication number: 20210116459
    Abstract: A method of determining the pre-eclampsia status of a pregnant subject, comprising providing a biological sample obtained from the subject; and determining the presence or absence, and/or level, of one or more of Type XVII collagen alpha 1, leptin, neprilysin, Filamin B and Scavenger receptor class B member 1 in the biological sample, and preferably comparing the level determined with a control.
    Type: Application
    Filed: April 11, 2019
    Publication date: April 22, 2021
    Inventors: Manu VATISH, Christopher REDMAN, Ian SARGENT, Adam CRIBBS, Gavin COLLETT, Wei ZHANG
  • Predictive test for pre-eclampsia
    Patent number: 6735529
    Abstract: A method is provided which enables a prediction to be made about the risk of a pregnant woman developing pre-eclampsia which comprises an analysis of the serum levels of screening markers, Inhibin A and free &bgr;-hCG. Apparatus for carrying out the determination of the risk of developing pre-eclampsia based on the analysis of the serum samples is also provided.
    Type: Grant
    Filed: June 6, 2001
    Date of Patent: May 11, 2004
    Assignees: Queen Mary & Westfield College, University of Oxford
    Inventors: Nicholas John Wald, Christopher Redman